ALISO VIEJO, Calif., Aug. 25 /PRNewswire/ — Ambry Genetics, a
global leader in genomic services, announced today that it has
acquired the Illumina HiSeq 2000 Next Generation Sequencing System
as well as received the first 510(K) approved Illumina BeadXpress
Genotyping System. Ambry Genetics has been an early adapter of
Illumina systems since late 2007 and has extensive experience as a
Certified Service Provider. A team of scientists routinely process
libraries for all available applications ranging from small RNAs to
whole genome DNA sequencing. Ambry has gained a solid
reputation for quality data and service as well as flexibility in
customizing projects to meet the specific needs of researchers.
(Logo: http://photos.prnewswire.com/prnh/20090428/LA06744LOGO)
(Logo: http://www.newscom.com/cgi-bin/prnh/20090428/LA06744LOGO)
The addition of the HiSeq 2000 will allow Ambry Genetics to run
large projects for its customers while saving costs and providing
the fastest turn-around times for sequencing. Ambry Genetics has an
experienced bioinformatics team that can generate custom reports,
providing flexible and results-driven informatics for sequencing
projects. In addition to sequencing, Ambry Genetics currently
offers diverse options for researchers interested in sequence
capture / target enrichment by utilizing Agilent Technologies
SureSelect, RainDance Technologies and Roche Nimblegen.
The new Illumina BeadXpress adds high-throughput genotyping
capabilities to Ambry Genetics’ existing line of services. The
BeadXpress uses GoldenGate assays on the VeraCode technology which
provides researchers with accuracy, flexibility and scalability for
their projects. The system supports high level variant
plexing and can process up to 96 samples per plate, which can
dramatically red
‘/>”/>
